Cardiothoracic & vascular anesthesia

The effects of video double-lumen tubes on intubation complications in patients undergoing thoracic surgery: A randomised controlled study

Eur J AnaesthesiolPublished Randomised controlled trial

Primary result · Moderate-to-severe tracheal injuryResult — go to the resultRelative risk 1.38 95% CI 0.97–1.95

Authors' conclusion

There was no statistically significant difference in the incidence of moderate-to-severe tracheal injury and vocal cord injury between DLTs and VDLTs. While improving the first-attempt success rate, intubation with VDLT increased the incidence of postoperative 24 h sore throat and hoarseness.

Study context

Population
Patients undergoing elective thoracic surgery with OLV, Xuzhou Cancer Hospital, China, January–June 2023
Participants
182 patients
Comparison
Video double-lumen tube vs conventional double-lumen tube for intubation
  • Double-lumen tube (DLT)n = 90reference
  • VDLTn = 92
Primary endpoint
Incidence of moderate-to-severe tracheal injury and incidence of vocal cord injury (recorded by fibreoptic bronchoscope)
Methodological detailssingle-centre
  • Single-centre

Primary result

Moderate-to-severe tracheal injury

Relative risk

1.38

95% CI 0.97–1.95

P = 0.077

Events by treatment group

VDLT vs DLT
RR 1.38 (95% CI 0.97–1.95); P = 0.077

As reported in the abstract

Secondary outcomes

Vocal cord injury (co-primary)

P = 0.449

Safety

OutcomeRR (95% CI)P value
Postoperative sore throat · 24 hSignificantly higher in the VDLT group1.63 (1.03–2.57)P = 0.032
Postoperative hoarseness · 24 hSignificantly higher in the VDLT group1.48 (1.06–2.06)P = 0.018

Original publication

The effects of video double-lumen tubes on intubation complications in patients undergoing thoracic surgery: A randomised controlled study. Eur J Anaesthesiol. Published 30 January 2024. doi:10.1097/eja.0000000000001959

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.